- FDA licenses Novavax COVID-19 Vaccine (Nuvaxovid) for selected adults; ACIP will consider recommendations for its use at its June meeting
- Immunize.org posts Pohnpeian translations of 16 VISs
- Immunize.org updates references in three more standing orders templates
- Confirmed measles cases increase to 1,046 across 30 states; encourage vaccination
- Questions about our website? Use your smartphone to watch our 2-minute video to learn about joining our live Website Office Hours.
- Vaccines in the news
- View the documentary Defeating a Virus That Killed Half a Billion People—The Plea, telling the story of the eradication of smallpox with the world’s first vaccine
- Vaccinate adults! Order laminated 2025 U.S. adult immunization schedule booklets.
- Immunize.org's elegantly designed "Vaccines Save Lives" black enamel pins make wonderful gifts or workplace recognitions!
- Virtual: Clinical Care Options hosts “Expert Answers to Best Practices to Turning Your Practice into a Vaccine Center of Excellence” on June 5 at 11:00 a.m. (ET) featuring Immunize.org’s L.J Tan; CE credit available
- Virtual: Register for Immunize.org Website Office Hours. Ask questions and learn about our "News & Updates" web section on June 11 at 4:00 p.m. (ET) or June 12 at 12:00 p.m. (ET). Recorded sessions archived.
On May 16, FDA licensed Nuvaxovid (Novavax) to prevent COVID-19 disease in adults age 65 years and older as well as those age 12 through 64 years with at least one underlying condition that elevates their risk for severe outcomes from COVID-19. Each dose contains 50 mcg of spike protein plus Matrix-M adjuvant. This is the only COVID-19 vaccine licensed in the United States not based on mRNA technology. The Novavax COVID-19 Vaccine had been offered under emergency use authorization since July 2022.
In June, ACIP is expected to consider its recommendations for use of COVID-19 vaccines for preventing COVID-19 disease.
FDA posted the Nuvaxovid package insert and approval letter.
Related Link
- Immunize.org: Vaccines A–Z: COVID-19 main page
Immunize.org continues to expand its repository of VIS translations, all available in print-ready PDF format. Cerro Gordo County Health Department, based in Mason City, Iowa, generously donated 16 Pohnpeian VIS translations, shown below. Pohnpeian is primarily spoken in the Federated States of Micronesia in the south Pacific.
- COVID-19* (view in English)
- Hepatitis B* (view in English)
- Haemophilus influenza type b (Hib) (view in English)
- Influenza (inactivated or recombinant)* (view in English)
- MMR* (Measles, Mumps, and Rubella) (view in English)
- MMRV* (view in English)
- Meningococcal B* (view in English)
- Multi-vaccine pediatric (view in English)
- Polio* (view in English)
- Pneumococcal conjugate (view in English)
- Rotavirus (view in English)
- RSV* (Respiratory Syncytial Virus) (view in English)
- Smallpox/Monkeypox* (view in English)
- Td (Tetanus, Diphtheria) (view in English)
- Varicella (Chickenpox)* (view in English)
- Zoster (Shingles) (view in English)
*Indicates that translations are out of date because they do not reflect the pronoun changes made in the January 31, 2025, versions of VISs that were altered to comply with a presidential executive order. As always, a copy of the current official VIS, in English, should be provided along with the translated VIS.
Related Links
- Immunize.org: Vaccine Information Statements main page for VISs in 47 languages
- Immunize.org: Dates of Current Vaccine Information Statements (PDF)
- CDC: What's New with VISs web page
- CDC: Current VISs web page
Immunize.org continues to update its standing orders templates to remove the reference to the excipient table that used to appear in Appendix B of the Epidemiology and Prevention of Vaccine-Preventable Diseases (the "Pink Book"). The three updated standing order templates posted in the past week are:
- Standing Orders for Administering Rotavirus Vaccine to Infants
- Standing Orders for Administering Human Papillomavirus Vaccine to Children and Teens (additional update to font and QR code)
- Standing Orders for Administering Human Papillomavirus Vaccine to Adults
- Standing Orders for Administering Hepatitis A Vaccine to Children and Teens
- Standing Orders for Administering Hepatitis A Vaccine to Adults
- Standing Orders for Administering Varicella Vaccine to Adults
- Standing Orders for Administering Varicella Vaccine to Children and Teens
- Standing Orders for Administering Haemophilus influenzae Type B Vaccine to Adults
- Standing Orders for Administering Pneumococcal Vaccines to Children and Teens
Related Links
- Immunize.org: Clinical Resources: Standing Orders Templates main page
- Immunize.org: Clinical Resources A–Z main page, where you can filter by topic, vaccine, language, or other criteria
As of May 23, CDC reported 1,046 confirmed measles cases in 2025 in 30 states. Most (728 of 1,046, 69.6%) were reported by the Texas Department of State Health Services. Among confirmed cases, 12% were hospitalized and two out of three were younger than age 20 years.
CDC only requires reporting of laboratory-confirmed measles cases. Cases without laboratory testing for confirmation are not included in these numbers. Actual numbers of cases are, therefore, expected to be higher than confirmed case counts.
A map of 2025 measles cases in the contiguous United States, as of May 23, from the Johns Hopkins Center for Outbreak Response Innovation (CORI) appears below. The CORI Measles Outbreak Response website offers various ways to visualize the outbreak.
CDC offers a suite of resources for public health, healthcare professionals, and families in communities experiencing a measles outbreak. Resources include infographics for families, images to help clinic personnel identify cases, and a Be Ready for Measles communication toolkit. A quick reference for healthcare professionals provides guidance for caring for patients with measles. Find all these resources on the CDC Measles Cases and Outbreaks page.
Related Links
- CDC: Measles Cases and Outbreaks main page
- CDC: Be Ready for Measles Toolkit
- Center for Outbreak Response Innovation: Measles Outbreak Response main page
- Immunize.org: Vaccines A–Z: Measles main page
- Immunize.org: Standing Orders for Administering Measles, Mumps, and Rubella Vaccine to Children and Teens (PDF)
- Immunize.org: Standing Orders for Administering Measles, Mumps, and Rubella Vaccine to Adults (PDF)
- Immunize.org: Ask the Experts: MMR (Measles, Mumps, and Rubella) web page
Questions about our website? Use your smartphone to watch our 2-minute video to learn about joining our live Website Office Hours.
Learn about Immunize.org’s Website Office Hours live and recorded webinars on the go with your smartphone. Check out the “mobile view” version of our 2-minute Orientation Video Series: Introducing Website Office Hours.
The entire Orientation Video Series is available on our YouTube channel.
Share these videos with anyone who wants to learn more about effective immunization practices with Immunize.org.
- Immunize.org: Webinars & Videos: Orientation Video Series page
- Facebook at ImmunizeOrg
- Instagram at ImmunizeOrg
- LinkedIn at ImmunizeOrg
- YouTube at ImmunizeOrg
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
- STAT: The FDA Is Circumventing Key Roles and Procedures for Licensure and Use of COVID Vaccines (5/22/25)
- CNN: FDA Requires COVID Vaccine Makers to Expand Warning About Risk of Rare Heart Inflammation (5/21/25)
- Contemporary Pediatrics: Maternal RSV Vaccine Data Reveal Uptake Disparities (5/20/25)
- Our World in Data: Measles Vaccines Save Millions of Lives Each Year (5/19/25)
- Medpage Today: New Dads, Non-Birthing Partners Less Likely to Get Prenatal Counseling on Vaccines (5/19/25)
- Medical Xpress: Study Finds Mix of Incentives, Texts, and Local Outreach Boosts Immunization Rates (5/19/25)
- Annenberg Public Policy Center: Americans Say Benefits of MMR Vaccine for Children Outweigh Risks by Nearly 5-1 (5/16/25)
This week, we spotlight our links to state-specific resources: State Immunization Websites and Additional State Resources. These can be found by choosing the Official Guidance tab from the main menu atop each web page, then selecting States from the left-hand menu.
Each state and the District of Columbia are included on the State Immunization Websites web page. Click on names to display additional content. Blue text indicates a hyperlink to directly access the state’s immunization program, plus available childcare, school, or college immunization requirements or related resources.
Additional State Resources connects you to important contact information for state immunization program managers and other important contacts (e.g., perinatal hepatitis B prevention and Indian Health Service programs). Links to other useful government and nongovernment organization sites are also provided.
Immunize.org updated a nonfunctioning URL in its Vaccine Storage Troubleshooting Record.
Defeating a Virus That Killed Half a Billion People—The Plea is a documentary that tells the story of the first vaccine and the eradication of smallpox. The 25-minute film shows the impact of smallpox through various historical periods, using graphics and art to demonstrate the impact of the virus. The documentary provides inspiration for the efforts to eradicate other diseases, including polio.
A portion of the narrative appears below:
People whose job it is to worry about measles or about whether we're prepared for future pandemics, or about those in poor countries where vaccines are out of reach—they're doing incredible work but need support to be successful. And you may notice that these days their pleas for help are too often going unanswered, which is why now feels like a good time to remember smallpox, to remember how many died, how many were saved, and what we're capable of.
The film is free to watch on YouTube.
Laminated booklets of the 2025 U.S. adult immunization schedule are still available in the Immunize.org shop. The 2025 child and adolescent schedule booklets sold out.
The schedules are available online as PDFs from CDC at no cost. Immunize.org’s laminated booklets are ideal for use in any busy healthcare setting where vaccines are given.
Pricing:
Adult Booklets
1 copy: $10.00
2–4 copies: $9.50 each
5–19 copies: $8.50 each
20–99 copies: $7.50 each
100–499 copies: $6.00 each
500–999 copies: $5.00 each
1,000–1,999 copies: $4.00 each
2,000+ copies: $3.25 each
Visit the Shop Immunize.org: Laminated Schedules web page to view images and order today!
For additional information, call 651-647-9009 or email admininfo@immunize.org.
Related Links
- Immunize.org: Laminated Adult Immunization Schedules (19 and older) web page
- Immunize.org: Shop Immunize.org main page
Immunize.org's elegantly designed "Vaccines Save Lives" black enamel pins make wonderful gifts or workplace recognitions!
Immunize.org’s elegantly designed “Vaccines Save Lives” pins are meaningful gifts for people who care about vaccination. The pin makes a refined statement in hard black enamel with gold lettering and edges, measuring 1.125" x 0.75". The pin features a stick-through-post with the back covered by a round rubber cap that holds the pin securely. A gold metal spring-lock clasp is also provided.
Wear these pins on clothing, uniforms, and white coats to show that you value vaccines.
Click here for "Vaccines Save Lives" pin pricing and ordering information.
In its May 16 issue, PLOS One published Menstrual Disturbance Associated with COVID-19 Vaccines: A Comprehensive Systematic Review and Meta-Analysis. The meta-analysis found an increased likelihood of brief menstrual cycle changes after COVID-19 vaccination. While noticeable, the temporary changes were not considered clinically meaningful. Portions of the abstract appear below.
Seventeen studies with >1.9 million participants were analyzed. We found a 19% greater risk of increase in menstrual cycle length as compared to unvaccinated people or pre-vaccination time-periods . . . In the first cycle after vaccination, length increased by [0.34 days] . . . after the first dose and by 0.62 days . . . after the second dose. In the second cycle after vaccination, the risk was not elevated . . . The increase in risk was between 7–9% but statistically insignificant for heavier flow; 7% for post-menopausal bleeding . . . and 16–41% for unexpected or intermenstrual bleeding . . .
We observed a mild increase in the risk of menstrual disturbance associated with COVID-19 vaccines. Such risks are likely clinically unmeaningful. Vaccine recipients should be appropriately counseled.
CDC published Estimated Current and Future Congenital Rubella Syndrome Incidence with and Without Rubella Vaccine Introduction—19 Countries, 2019–2055 on May 22 in MMWR. A portion of the summary appears below.
Rubella infection during early pregnancy can result in miscarriage, fetal death, or a constellation of birth defects known as congenital rubella syndrome (CRS). By 2023, among 194 World Health Organization member countries, 175 (90%) had introduced a rubella-containing vaccine (RCV) into their routine immunization program. . . .
In this modeling study of vaccination, in the 19 countries that have not introduced RCV and where an estimated 24,000 CRS cases occurred in 2019, universal RCV introduction during 2025–2055 would avert an estimated 986,000 CRS cases. In 2024, based on these estimates and other considerations, the World Health Organization recommended universal RCV introduction in these 19 countries. . . .
Universal RCV introduction during the next 5 years could accelerate progress toward rubella and CRS elimination worldwide.
Access the MMWR article in HTML or PDF.
Related Links
- CDC: MMWR main page providing access to the MMWR family of publications
- Immunize.org: Vaccines A–Z: RSV (Respiratory Syncytial Virus) main page
Upcoming Events
Clinical Care Options will host an event titled Expert Answers to Best Practices to Turning Your Practice into a Vaccine Center of Excellence at 11:00 a.m. (ET) on June 5. During this webinar, expert faculty will answer questions regarding vaccine management, how to be a vaccine expert for your patients, and how to optimize immunization in clinical practice. The webinar will feature Immunize.org's L.J Tan, MS, PhD, and Robert H. Hopkins, Jr., MD, MACP, of the National Foundation for Infectious Diseases.
CME, CNE, and CPE credit is available at no charge.
Register for the event.
Virtual: Register for Immunize.org Website Office Hours. Ask questions and learn about our "News & Updates" web section on June 11 at 4:00 p.m. (ET) or June 12 at 12:00 p.m. (ET). Recorded sessions archived.
To learn simple tips and tricks for using our website efficiently, please register for our next set of Website Office Hours on Wednesday, June 11 at 4:00 p.m. (ET) or Thursday, June 12 at 12:00 p.m. (ET). The same content will be covered in both sessions.
We will open each 45-minute session with a short, live demonstration on navigating our News & Updates website section. You can submit questions when you register or live on Zoom during the session.
Register today for Immunize.org Website Office Hours (content is the same for both):
The archive of previous Website Office Hours content is posted at Immunize.org’s "Webinars & Videos" page. These archived programs include Ask the Experts; Clinical Resources; Vaccine Information Statements (VISs); Affiliated Websites; Images, Webinars, Videos, & Social Media; Official Guidance; Publication Archives, Vaccine Timeline, & About Us; Travel Vaccines, Vaccine Confidence, & Addressing Concerns; and Vaccines A–Z.
See our Calendar of Events for future Immunize.org Website Office Hours.
For more upcoming events, visit our Calendar of Events.